Improving Alzheimer's diagnosis with biomarker testing
Part of Brain & nervous system, Mental health clinical trials.
This study aims to improve access to Alzheimer's disease diagnostics by using biomarkers (like blood tests or brain scans) to confirm whether your memory problems are caused by Alzheimer's disease. Participating could help you get a more accurate diagnosis and guide your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old.
- You have mild memory problems or early dementia, even if you haven't been officially diagnosed.
- You score between 10 and 28 on the MoCA memory test (your doctor can check this).
- Your memory problems are likely due to Alzheimer's disease—not another cause like stroke, Parkinson's, or head injury.
- You do not have severe mental health conditions (like schizophrenia or current major depression) that would interfere.
- You can complete assessments in English and provide your own consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study checks Alzheimer’s “core biomarkers” to find the best cut-off values for diagnosing Alzheimer’s disease and related conditions. It may help doctors more accurately tell Alzheimer’s, mild cognitive changes, and other causes of memory problems apart.
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
This study looks at brain changes in people with mild memory problems to find early signs of Alzheimer's disease. You and a study partner can help by sharing information about your daily life.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study looks for “biomarkers” (measurable signs from blood and brain tests) that may help predict who with mild cognitive impairment (MCI) could later develop dementia. Results may help doctors spot risk earlier and better plan care.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.